Literature DB >> 20464730

Exercise therapy for schizophrenia.

Paul Gorczynski1, Guy Faulkner.   

Abstract

BACKGROUND: The health benefits of physical activity and exercise are well documented and these effects could help people with schizophrenia.
OBJECTIVES: To determine the mental health effects of exercise/physical activity programmes for people with schizophrenia or schizophrenia-like illnesses. SEARCH STRATEGY: We searched the Cochrane Schizophrenia Group Trials Register (December 2008) which is based on regular searches of CINAHL, EMBASE, MEDLINE and PsycINFO. We also inspected references within relevant papers. SELECTION CRITERIA: We included all randomised controlled trials comparing any intervention where physical activity or exercise was considered to be the main or active ingredient with standard care or other treatments for people with schizophrenia or schizophrenia-like illnesses. DATA COLLECTION AND ANALYSIS: We independently inspected citations and abstracts, ordered papers, quality assessed and data extracted. For binary outcomes we calculated a fixed-effect risk ratio (RR) and its 95% confidence interval (CI). Where possible, the weighted number needed to treat/harm statistic (NNT/H) and its 95% confidence interval (CI), was also calculated. For continuous outcomes, endpoint data were preferred to change data. We synthesised non-skewed data from valid scales using a weighted mean difference (WMD). MAIN
RESULTS: Three randomised controlled trials met the inclusion criteria. Trials assessed the effects of exercise on physical and mental health. Overall numbers leaving the trials were similar. Two trials (Beebe 2005 and Marzaloni 2008) compared exercise to standard care and both found exercise to significantly improve negative symptoms of mental state (Mental Health Inventory Depression: 1RCT, n=10, MD 17.50 CI 6.70 to 28.30, PANNS negative: 1RCT, n=10, MD -8.50 CI -11.11 to -5.89). No absolute effects were found for positive symptoms of mental state. Physical health improved significantly in the exercise group compared to those in standard care (1RCT, n=13, MD 79.50 CI 33.82 to 125.18), but no effect on peoples' weight/BMI was apparent. Duraiswamy 2007 compared exercise with yoga and found that yoga had a better outcome for mental state (PANNS total: 1RCT, n=41, MD 14.95 CI 2.60 to 27.30). The same trial also found those in the yoga group had significantly better quality of life scores (WHOQOL Physical: 1RCT, n=41, MD -9.22 CI -18.86 to 0.42). Adverse effects (AIMS total scores) were, however, similar. AUTHORS'
CONCLUSIONS: Results of this Cochrane review are similar to existing reviews that have examined the health benefits of exercise in this population (Faulkner 2005). Although studies included in this review are small and used various measures of physical and mental health, results indicated that regular exercise programmes are possible in this population, and that they can have healthful effects on both the physical and mental health and well-being of individuals with schizophrenia. Larger randomised studies are required before any definitive conclusions can be drawn.

Entities:  

Mesh:

Year:  2010        PMID: 20464730      PMCID: PMC4164954          DOI: 10.1002/14651858.CD004412.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  41 in total

Review 1.  Systematic reviews in health care: Assessing the quality of controlled clinical trials.

Authors:  P Jüni; D G Altman; M Egger
Journal:  BMJ       Date:  2001-07-07

Review 2.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

3.  Issues in the meta-analysis of cluster randomized trials.

Authors:  Allan Donner; Neil Klar
Journal:  Stat Med       Date:  2002-10-15       Impact factor: 2.373

4.  Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials.

Authors:  Isabelle Boutron; Florence Tubach; Bruno Giraudeau; Philippe Ravaud
Journal:  J Clin Epidemiol       Date:  2004-06       Impact factor: 6.437

5.  The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group.

Authors:  S M Skevington; M Lotfy; K A O'Connell
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

6.  The effects of physical exercises to mental state and quality of life in patients with schizophrenia.

Authors:  A A Acil; S Dogan; O Dogan
Journal:  J Psychiatr Ment Health Nurs       Date:  2008-12       Impact factor: 2.952

7.  A rating scale for extrapyramidal side effects.

Authors:  G M Simpson; J W Angus
Journal:  Acta Psychiatr Scand Suppl       Date:  1970

8.  The structure of psychological distress and well-being in general populations.

Authors:  C T Veit; J E Ware
Journal:  J Consult Clin Psychol       Date:  1983-10

9.  Movement therapy with psychotic adolescents.

Authors:  A Apter; I Sharir; S Tyano; H Wijsenbeek
Journal:  Br J Med Psychol       Date:  1978-06

10.  Medical comorbidity in schizophrenia.

Authors:  Timothy J R Lambert; Dennis Velakoulis; Christos Pantelis
Journal:  Med J Aust       Date:  2003-05-05       Impact factor: 7.738

View more
  55 in total

Review 1.  [Psychosocial interventions in severe mental illness: evidence and recommendations: psychoeducation, social skill training and exercise].

Authors:  S G Riedel-Heller; U Gühne; S Weinmann; K Arnold; E-S Ay; T Becker
Journal:  Nervenarzt       Date:  2012-07       Impact factor: 1.214

2.  Using internet enabled mobile devices and social networking technologies to promote exercise as an intervention for young first episode psychosis patients.

Authors:  Eoin Killackey; Anna Lee Anda; Martin Gibbs; Mario Alvarez-Jimenez; Andrew Thompson; Pamela Sun; Gennady N Baksheev
Journal:  BMC Psychiatry       Date:  2011-05-12       Impact factor: 3.630

Review 3.  Non Pharmacological Cognitive Enhancers - Current Perspectives.

Authors:  Ankur Sachdeva; Kuldip Kumar; Kuljeet Singh Anand
Journal:  J Clin Diagn Res       Date:  2015-07-01

Review 4.  Exercise as a Treatment for Schizophrenia: A Review.

Authors:  Steven J Girdler; Jamie E Confino; Mary E Woesner
Journal:  Psychopharmacol Bull       Date:  2019-02-15

5.  Improving Cognition via Exercise (ICE): Study Protocol for a Multi-Site, Parallel-Group, Single-Blind, Randomized Clinical Trial Examining the Efficacy of Aerobic Exercise to Improve Neurocognition, Daily Functioning, and Biomarkers of Cognitive Change in Individuals with Schizophrenia.

Authors:  Luz H Ospina; Melanie Wall; Lars F Jarskog; Jacob S Ballon; Joseph McEvoy; Matthew N Bartels; Richard Buchsbaum; Richard P Sloan; T Scott Stroup; David Kimhy
Journal:  J Psychiatr Brain Sci       Date:  2019-12-30

6.  Exercise Treatments for Psychosis: A Review.

Authors:  Vijay A Mittal; Teresa Vargas; K Juston Osborne; Derek Dean; Tina Gupta; Ivanka Ristanovic; Christine I Hooker; Stewart A Shankman
Journal:  Curr Treat Options Psychiatry       Date:  2017-04-18

Review 7.  [Physical training for neurological and mental diseases].

Authors:  K Henkel; C D Reimers; G Knapp; F Schneider
Journal:  Nervenarzt       Date:  2014-12       Impact factor: 1.214

Review 8.  S3 guideline on psychosocial therapies in severe mental illness: evidence and recommendations.

Authors:  Uta Gühne; Stefan Weinmann; Katrin Arnold; Thomas Becker; Steffi G Riedel-Heller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-11-11       Impact factor: 5.270

Review 9.  Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?

Authors:  Hiram Joseph Wildgust; Mike Beary
Journal:  J Psychopharmacol       Date:  2010-11       Impact factor: 4.153

10.  Exercise reveals the interrelation of physical fitness, inflammatory response, psychopathology, and autonomic function in patients with schizophrenia.

Authors:  Stefanie Ostermann; Marco Herbsleb; Steffen Schulz; Lars Donath; Sandy Berger; Daniela Eisenträger; Tobias Siebert; Hans-Josef Müller; Christian Puta; Andreas Voss; Holger W Gabriel; Kathrin Koch; Karl-Jürgen Bär
Journal:  Schizophr Bull       Date:  2012-09-10       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.